Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Main Inclusion Criteria: * Written informed consent * General good health other than seasonal allergic rhinitis * Positive standard skin prick test Main Exclusion Criteria: * Pregnancy, nursing, or plans to become pregnant or donate gametes for in vitro fertilization * Participation in any investigational drug trial within the 30 days preceding the Screening Visit * A known hypersensitivity to any corticosteroid or any of the ingredients in the study drug formulation * Plans to travel outside the study area (the known pollen area for the investigative site) for 24 hours or more during the final 7 days of the baseline period * Plans to travel outside the study area (the known pollen area for the investigative site) for more than 2 consecutive days OR more than 3 days total during the treatment period * Use of any prohibited concomitant medications * Non-vaccinated exposure to or active infection with chickenpox or measles within the 21 days preceding the Screening Visit * Use of antiepileptic drugs for epilepsy within 30 days of the Screening Visit * Study participation by more than one patient from the same household